169 related articles for article (PubMed ID: 9811433)
1. Selectivity of atipamezole, yohimbine and tolazoline for alpha-2 adrenergic receptor subtypes: implications for clinical reversal of alpha-2 adrenergic receptor mediated sedation in sheep.
Schwartz DD; Clark TP
J Vet Pharmacol Ther; 1998 Oct; 21(5):342-7. PubMed ID: 9811433
[TBL] [Abstract][Full Text] [Related]
2. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.
Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the subtypes of alpha2-adrenoceptor mediating prejunctional inhibition in rat atrium and cerebral cortex.
Ho SL; Honner V; Docherty JR
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):634-9. PubMed ID: 9686939
[TBL] [Abstract][Full Text] [Related]
4. Reversal of medetomidine sedation in sheep by atipamezole and yohimbine.
Mohammad FK; Zangana IK; Abdul-Latif AR
Vet Hum Toxicol; 1995 Apr; 37(2):97-9. PubMed ID: 7631500
[TBL] [Abstract][Full Text] [Related]
5. Affinity of detomidine, medetomidine and xylazine for alpha-2 adrenergic receptor subtypes.
Schwartz DD; Clark TP
J Vet Pharmacol Ther; 1998 Apr; 21(2):107-11. PubMed ID: 9597647
[TBL] [Abstract][Full Text] [Related]
6. Effects of three antagonists on selected pharmacodynamic effects of sublingually administered detomidine in the horse.
Knych HK; Stanley SD
Vet Anaesth Analg; 2014 Jan; 41(1):36-47. PubMed ID: 24134603
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological evidence for different alpha 2-adrenergic receptor sites mediating analgesia and sedation in the rat.
Buerkle H; Yaksh TL
Br J Anaesth; 1998 Aug; 81(2):208-15. PubMed ID: 9813525
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effects of a specific alpha 2-adrenoceptor antagonist, atipamezole, on alpha 1- and alpha 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine.
Haapalinna A; Viitamaa T; MacDonald E; Savola JM; Tuomisto L; Virtanen R; Heinonen E
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):570-82. PubMed ID: 9402036
[TBL] [Abstract][Full Text] [Related]
9. Atipamezole, an imidazoline-type alpha(2)-adrenoceptor inhibitor, binds to human platelets and inhibits their adrenaline-induced aggregation more effectively than yohimbine.
Mustonen P; Savola J; Lassila R
Thromb Res; 2000 Aug; 99(3):231-7. PubMed ID: 10942789
[TBL] [Abstract][Full Text] [Related]
10. The affinity and selectivity of α-adrenoceptor antagonists, antidepressants and antipsychotics for the human α2A, α2B, and α2C-adrenoceptors and comparison with human α1 and β-adrenoceptors.
Proudman RGW; Akinaga J; Baker JG
Pharmacol Res Perspect; 2022 Apr; 10(2):e00936. PubMed ID: 35224877
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
Bock C; Niederhoffer N; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
[TBL] [Abstract][Full Text] [Related]
12. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers.
Scheinin H; Aantaa R; Anttila M; Hakola P; Helminen A; Karhuvaara S
Anesthesiology; 1998 Sep; 89(3):574-84. PubMed ID: 9743392
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist.
Pertovaara A; Haapalinna A; Sirviö J; Virtanen R
CNS Drug Rev; 2005; 11(3):273-88. PubMed ID: 16389294
[TBL] [Abstract][Full Text] [Related]
14. Expression of functional alpha2-adrenergic receptor subtypes in human corpus cavernosum and in cultured trabecular smooth muscle cells.
Traish AM; Moreland RB; Huang YH; Goldstein I
Recept Signal Transduct; 1997; 7(1):55-67. PubMed ID: 9285531
[TBL] [Abstract][Full Text] [Related]
15. Reversal of sedative and clinicophysiological effects of epidural xylazine and detomidine with atipamezole and yohimbine in buffaloes (Bubalus bubalis).
Tiwari SK; Kumar A; Vainio O
Vet Rec; 1998 Nov; 143(19):529-32. PubMed ID: 9839365
[TBL] [Abstract][Full Text] [Related]
16. Influence of yohimbine and atipamezole on haemodynamics and ECG after lumbosacral subarachnoid administration of medetomidine in goats.
Kinjavdekar P; Amarpal GR; Pawde AM; Aithal HP; Gupta OP
J Vet Med A Physiol Pathol Clin Med; 2003 Oct; 50(8):424-31. PubMed ID: 14633222
[TBL] [Abstract][Full Text] [Related]
17. Yohimbine disrupts prepulse inhibition in rats via action at 5-HT1A receptors, not alpha2-adrenoceptors.
Powell SB; Palomo J; Carasso BS; Bakshi VP; Geyer MA
Psychopharmacology (Berl); 2005 Jul; 180(3):491-500. PubMed ID: 15719216
[TBL] [Abstract][Full Text] [Related]
18. Occurrence, pharmacology and function of presynaptic alpha2-autoreceptors in alpha2A/D-adrenoceptor-deficient mice.
Trendelenburg AU; Hein L; Gaiser EG; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):540-51. PubMed ID: 10598793
[TBL] [Abstract][Full Text] [Related]
19. A study of presynaptic alpha2-autoreceptors in alpha2A/D-, alpha2B- and alpha2C-adrenoceptor-deficient mice.
Trendelenburg AU; Klebroff W; Hein L; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Aug; 364(2):117-30. PubMed ID: 11534851
[TBL] [Abstract][Full Text] [Related]
20. Effects of imidazoline derivatives on cholinergic motility in guinea-pig ileum: involvement of presynaptic alpha2-adrenoceptors or imidazoline receptors?
Colucci R; Blandizzi C; Carignani D; Placanica G; Lazzeri G; Del Tacca M
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):682-91. PubMed ID: 9686946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
